After completing the course, you will be able to:
-
Outline the principles of pharmacovigilance
-
Explain the major steps in pharmacovigilance signal management
- List the key stakeholders in pharmacovigilance and their roles
-
Compare Post Authorisation Safety Studies (PASS) and Post Authorisation Efficacy Studies (PAES)
-
Outline the organisation of public hearings
- Explain the concept and structure of EudraVigilance
-
Outline the principles of risk management for medicinal products in the European Union (EU) including the risk management plan
- Explain the EU specific measures for additional monitoring
- Outline the concept of safety communication
- Relate the ‘Direct to health care professionals communication’ to the overall principles of safety communication
Duration: 8 hours
